


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 7 Apr 2016
VolitionRx Announces CE Marks for Two NuQ(R) Blood Assays for Detection of Colorectal Cancer
VolitionRx Announces CE Marks for Two NuQ(R) Blood Assays for Detection of Colorectal Cancer
HSMN NewsFeed - 6 Apr 2016
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
HSMN NewsFeed - 4 Apr 2016
BioLineRx's Novel Treatment for Non-Surgical Removal of Skin Lesions Receives CE Mark Approval
BioLineRx's Novel Treatment for Non-Surgical Removal of Skin Lesions Receives CE Mark Approval
HSMN NewsFeed - 22 Mar 2016
Varian Launches New Smaller Calypso Beacon Transponder To Guide Radiation Therapy In Soft Tissue Tumors
Varian Launches New Smaller Calypso Beacon Transponder To Guide Radiation Therapy In Soft Tissue Tumors
HSMN NewsFeed - 21 Mar 2016
LEO Pharma Receives Scientific Approval of Enstilar(R) for the Treatment of Psoriasis in EU
LEO Pharma Receives Scientific Approval of Enstilar(R) for the Treatment of Psoriasis in EU
HSMN NewsFeed - 9 Mar 2016
NuVasive Announces Regulatory Approval of Reline(TM) Posterior Fixation Technology in Japan
NuVasive Announces Regulatory Approval of Reline(TM) Posterior Fixation Technology in Japan
HSMN NewsFeed - 26 Feb 2016
Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis
Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis
